International Journal of Pharmaceutical Sciences Research Volume 1 (2014), Article ID 1:IJPSR-102, 6 pages
http://dx.doi.org/10.15344/2394-1502/2014/102
http://dx.doi.org/10.15344/2394-1502/2014/102
Research Article
Determination of Lortatadine in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS) and its Pharmacokinetic Application
References
- Kassem N, Roman l, Gural R, Dver JG, Robillard N (1988) Effects of loratadine (SCH 29851) in suppression of histamine-induced Skin wheals. Ann Allergy 60: 505-507 View
- Barenholtz AH, McLeod DC (1989) Loratadine: a nonsedating antihistamine with once-daily dosing. DICP 23: 445-450. View
- Kay GG, Harris AG. (1999) Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin Exp Allergy 3: 147-150. View
- Claritin Redi Tabs 5 mg Tablet, Clinical pharmacology and biopharmaceutics Review (2006) NDA 21-993, page 4.
- Hilbert J1, Radwanski E, Weglein R, Luc V, Perentesis G, et al. (1987) Pharmacokinetics and dose proportionality of loratadine, J Clin Pharmacol 9: 694-698. View
- Kenilworth NJ (2000) Claritin Tables, syrup and rapidly disintegrating tablets prescribing information, Schring Crop.
- US Food and Drug Administration, CDER Data Standards Manual, 2003. View
- European Directorate for quality of Medicines. View
- Song JH, Shin SC (2009) Development of the loratadine gel for enhanced transdermal delivery. Drug Dev Ind Pharm. 8: 897-903. View
- Villacampa J, Alcantar F, Rodriguez JM, Morales JM, Herrera J, et al. (2003) Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy men. Clin Ther 8: 2225-2232. View
- Pavalache G, Dorneanu V (2011) Validation Of An Analytical Method Based On High Performance Liquid Chromatography For Determination Of Loratadine In Pharmaceutical Preparations And Biological Environments. FARMACIA 59: 2. View
- Zhong D, Blume H (1994) HPLC-determination of loratadine and its active metabolite descarboethoxyloratadine in human plasma Pharmazie. 49: 736-739. View
- Vlase L, Imre S, Muntean D, Leucuta SE., (2007) Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detection, J Pharm Biomed Anal.3: 652- 657. View
- Dordevic S, Rusic B, Denic K, Kilibarda V, Vukcevic-Perkovic N, et al. (2013) Simultaneous Determination Of Loratadine And Descarboethoxylo-Ratadine In Human Serum By High-Per-Formance Liquid Chromatography (HPLC) – Atmospheric Pressure Chemical Ionization-Mass Spectrometry (APCI-LC-MS) Method. MD-Medical Data 1: 027-030. View
- Naidong W, Addison T, Schneider T, Jiang X, Halls TD (2003) A sensitive LC/ MS/MS method using silica column and aqueous-organic mobile phase for the analysis of loratadine and descarboethoxy-loratadine in human plasma. J Pharm Biomed Anal 32: 609-617. View
- CFR 2013, subpart B, Section 320.26: Guidelines on the design of a singledose in vivo bioavailability or bioequivalence study Ch.I (4-1-13), page 198.
- Guidance for Industry Bioanalytical method Validation. View
- Guidance for Industry (2003) Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations. View
- Choi YW, Nam D, Kang KH,Ha KW, Han IH, et al. (2006) High-Performance Liquid Chromatographic-Tandem Mass Spectrometric Determination of Itraconazole in Human Plasma for Bioavailability and Bioequivalence Studies. Bull Korean Chem Soc 27: 291. View
- (Study CL2004-01) Claritin Redi Tabs 5 mg Tablet, Clinical pharmacology and biopharmaceutics Review, NDA 21-993, page 11.